School of Medicine
Showing 1-8 of 8 Results
-
Alyce Sophia Adams
Stanford Medicine Innovation Professor and Professor of Epidemiology and Population Health, of Health Policy and, by courtesy, of Pediatrics (Endocrinology)
BioDr. Adams is the inaugural Stanford Medicine Innovation Professor and Professor of Health Policy, Epidemiology and Population Health and of Pediatrics (by Courtesy). She also serves as Associate Chair for Community Outreach and Engagement for Stanford Health Policy, and as Associate Director for Partnership and Community Engagement in the Stanford Cancer Institute. Focusing on pharmaceutical treatments for cancer and diabetes, Dr. Adams' research evaluates health system and policy level interventions to improve access, balance the benefits and harms of treatment, improve patient-valued outcomes, and reduce disparities. Prior to joining Stanford School of Medicine, Dr. Adams was Associate Director for Health Care Delivery and Policy and a Research Scientist at the Kaiser Permanente Division of Research, as well as a Professor at the Bernard J. Tyson Kaiser Permanente School of Medicine. From 2000 to 2008, she was an Assistant Professor in the Department of Population Medicine (formerly Ambulatory Care and Prevention) at Harvard Medical School and Harvard Pilgrim Health Care. She received her PhD in Health Policy and an MPP in Social Policy from Harvard University. She is a member of the Stanford University Faculty Senate and a former recipient of the John M. Eisenberg Excellence in Mentoring Award from Agency for Healthcare Research and Quality.
-
Jason Andrews
Professor of Medicine (Infectious Diseases) and, by courtesy, of Epidemology
Current Research and Scholarly InterestsOur laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.
-
Jason Arora MD, MPH, MA
Affiliate, Epidemiology and Population Health
Visiting Scholar, Epidemiology and Population HealthBioDr. Jason Arora is a Visiting Scholar at the Department of Epidemiology & Population Health at Stanford University School of Medicine, where he focuses on the development and deployment of AI applications in population health.
He holds degrees in Medicine and Medical Sciences from Oxford University and in Public Health from Harvard University, and is a former NHS physician, Fulbright Scholar, and Aspen Health Fellow.
Dr. Arora has spent nearly two decades building and leading innovation efforts across healthcare, population health, and life sciences at some of the world's leading companies, including Google Life Sciences (Head of Clinical Science Innovation and Medical Affairs), Medtronic (Director of Value-Based Care), The Gates Foundation (AI Strategy Lead, Global Health), and ICHOM (Director; a non-profit joint venture co-founded by BCG, The Karolinska Institutet, and Harvard Business School). He is an experienced senior operator with a track record of building and leading large global teams across disciplines and sectors - including health systems, care models and quality improvement, clinical trials, digital health and AI, payment models, policy and regulation, medical devices, consumer health, and biotechnology.
Recognized as a Forbes 30 Under 30 lister in Healthcare and Science, and as a recipient of the Harvard Public Health Alumni Innovator Award and Lord Mayor of London & Guild of Freemen National Prize, Dr. Arora continues to serve as a judge for the Zayed Sustainability Prize administered by the Government of Abu Dhabi, and was previously a judge for Harvard’s Public Health Alumni Awards and an Honorary Fellow of The Royal Society of Arts.
He is a frequent keynote speaker and his work and commentary have appeared in top-tier journals and media, including the New England Journal of Medicine (NEJM) Catalyst, Harvard Business Review, BMJ, The Economist, Forbes, and JACC. -
Themistocles (Tim) Assimes
Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsGenetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes
